Haverford Financial Services, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Haverford Financial Services, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$7,413,179
-5.4%
145,442
-0.0%
2.04%
-14.8%
Q3 2022$7,837,000
-16.2%
145,508
-0.0%
2.40%
-11.8%
Q2 2022$9,350,000
-20.5%
145,563
-4.0%
2.72%
-6.0%
Q1 2022$11,757,000
-10.3%
151,624
-0.7%
2.90%
-2.4%
Q4 2021$13,111,000
+2.9%
152,738
-3.6%
2.97%
-4.3%
Q3 2021$12,745,000
-0.2%
158,462
-0.1%
3.10%
-0.6%
Q2 2021$12,769,000
-4.6%
158,626
-0.1%
3.12%
-10.8%
Q1 2021$13,387,000
+39.0%
158,730
+32.3%
3.50%
+33.3%
Q4 2020$9,631,000
+26.4%
120,022
+26.7%
2.62%
+12.0%
Q3 2020$7,617,000
-5.2%
94,721
+1.5%
2.34%
-13.4%
Q2 2020$8,033,000
+29.5%
93,304
+22.1%
2.71%
+7.9%
Q1 2020$6,205,000
-3.0%
76,426
-0.1%
2.51%
+23.2%
Q4 2019$6,400,000
-8.2%
76,534
-4.0%
2.04%
-14.0%
Q3 2019$6,971,000
+6.4%
79,700
-0.3%
2.36%
+4.0%
Q2 2019$6,549,000
+0.2%
79,961
-0.5%
2.28%
-2.9%
Q1 2019$6,534,000
+24.1%
80,358
+0.5%
2.34%
+8.0%
Q4 2018$5,263,000
-14.6%
79,962
-0.0%
2.17%
-0.7%
Q3 2018$6,166,000
+3.2%
79,980
-1.1%
2.19%
-2.5%
Q2 2018$5,972,000
+11.9%
80,872
-1.4%
2.24%
+10.5%
Q1 2018$5,336,000
-0.8%
82,049
-1.4%
2.03%
+3.3%
Q4 2017$5,381,000
+2.5%
83,238
-0.5%
1.96%
-4.2%
Q3 2017$5,249,000
+3.0%
83,655
-0.6%
2.05%
-1.1%
Q2 2017$5,094,000
+11.7%
84,136
-4.3%
2.08%
+10.5%
Q1 2017$4,561,000
+15.3%
87,951
-1.5%
1.88%
+12.5%
Q4 2016$3,957,000
-7.4%
89,247
-0.6%
1.67%
-9.1%
Q3 2016$4,272,000
-2.2%
89,750
-7.1%
1.84%
-0.4%
Q2 2016$4,368,000
+3.1%
96,600
-6.3%
1.84%
+3.2%
Q1 2016$4,235,000103,0961.79%
Other shareholders
BAXTER INTL INC shareholders Q3 2018
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders